SIGN IN
|
SIGN UP
ISSN 0973 - 9289
HOME
(current)
TOPICS
ASK A DOCTOR
GRAND ROUNDS
Question of the week
BLOGS
SUBMIT
CONFERENCE
VIDEOS
January 2014 NEWSLETTER
Newsletter
2014
January
January 2014 Newsletter
HAPPY NEW YEAR
Wish you a very happy and prosperous 2014. Our new launch in 2014 is the updated Pediatric Oncall website. Check out
www.pediatriconcall.com
GRAND ROUNDS
A 5½ years old boy presented with loss of appetite and intermittent fever since 6 months. He had bilateral parotid enlargement since past 3 years and jaundice 2 years back. He had weight loss, recurrent diarrhea also. He was on antituberculous therapy since past 8 months in view of Miliary TB. He had also tested positive for candida on sputum examination and was on fluconazole since 3½ months. He was detected to be HIV infected 2 months back and was referred for further management. On examination, he was malnourished. Systemic examination revealed hepatosplenomegaly with bilateral fine crepitations in the lung fields. His investigations showed nodular shadows on the X-Ray Chest. CD4 count was 343/cumm with CD4:CD8 ratio of 0.43. He was started on Antiretroviral therapy (ART) consisting of Zidovudine (AZT), Lamivudine (3TC) and Efavirenz (EFV) and continued on 2 drug ATT with trimethoprim-sulfamethoxazole (TMP-SMX) prophylaxis.
After 3 months, he presented with herpes zoster in right foot which responded to oral acyclovir. At that time CD4 count was 800/cumm
Is this treatment failure?
>>
Read More...
Question Of the Day
Is ART which is widely used in our country any different from so called HAART used for AIDS in developed countries? If so what is the difference?
>>
Answer Now...
>>
HIV BLOGS
>>
ASK EXPERTS
SUBMIT TO HIV IN CHILDREN
HIV IN CHILDREN ensures that your scientific research gets the maximum coverage and visibility both internationally and nationally that it deserves. SUBMIT TO HIV IN CHILDREN - HAVE A GLOBAL PRESENCE
>>
Submit Now
HIV ARTICLE
>>
Treatment of HIV In Special Situations
PARTNER SITES
>>
Pediatric Oncall
>>
Medical Adris
>>
Vaccine Reminder
HIV GRAND ROUNDS
A 32 years old HIV infected pregnant female (G2P2L1) presented at 36 weeks of pregnancy for deciding neonatal antiretroviral (ARV) prophylaxis. Her HIV viral load at 34 weeks of gestation was undetectable and she was on antiretroviral therapy (ART) consisting ....
HIV IN CHILDREN APPS